PURPOSE
Comparison
Comparison of biologic risk profile to MSKCC
STUDY
999 patients. Biologic risk profile vs. MSKCC weighted clin/path risk.
SUMMARY
- Biologic Risk Profile reclassified 59% of the clin/path low risk group and 27% of the clin/path high risk group